SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-003254
Filing Date
2017-05-02
Accepted
2017-05-02 16:02:18
Documents
52
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20170331x10q.htm 10-Q 1363460
2 EX-31.1 rigl-20170331ex311b55fe4.htm EX-31.1 17854
3 EX-31.2 rigl-20170331ex312a94ca5.htm EX-31.2 17876
4 EX-32.1 rigl-20170331ex321b99e37.htm EX-32.1 9413
  Complete submission text file 0001558370-17-003254.txt   4304545

Data Files

Seq Description Document Type Size
5 EX-101.INS rigl-20170331.xml EX-101.INS 807524
6 EX-101.SCH rigl-20170331.xsd EX-101.SCH 32807
7 EX-101.CAL rigl-20170331_cal.xml EX-101.CAL 36598
8 EX-101.DEF rigl-20170331_def.xml EX-101.DEF 104228
9 EX-101.LAB rigl-20170331_lab.xml EX-101.LAB 286178
10 EX-101.PRE rigl-20170331_pre.xml EX-101.PRE 204405
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 17804931
SIC: 2834 Pharmaceutical Preparations